Rafferty Asset Management, LLC Cabaletta Bio, Inc. Transaction History

Rafferty Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.22 - $18.82 $1.81 Million - $4.72 Million	-250,842 Reduced 70.77%	103,582 $774,000
Q1 2024 May 13, 2024	BUY	$16.79 - $25.38 $2.44 Million - $3.68 Million	145,161 Added 69.37%	354,424 $6.05 Million
Q4 2023 Feb 13, 2024	BUY	$12.21 - $23.36 $1.11 Million - $2.13 Million	91,113 Added 77.12%	209,263 $4.75 Million
Q3 2023 Nov 13, 2023	BUY	$11.84 - $18.65 $1.4 Million - $2.2 Million	118,150 New	118,150 $1.8 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.